First-line Afatinib plus Cetuximab for EGFR-mutant Non-small-cell Lung Cancer: Results from the Randomized Phase 2 IFCT-1503 ACE-Lung Study

  • Etude concernée: IFCT-1503
  • Auteurs / Authors: Cortot AB, Madroszyk-Flandin A, Giroux Leprieur E, Molinier O, Quoix E, Berard H, Otto J, Rault I, Moro-Sibilot D, Raimbourg J, Amour E, Morin F, Hureaux J, Moreau L, Debieuvre D, Morel H, Renault A, Pichon E, Huret B, Charpentier S, Denis MG, Cadranel J.
  • Journal / Conference: Clinical Cancer Research
  • Année / Year: 2021
  • PMID: 34031056
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/34031056/
  • PDF: Ace_lung_CCR.pdf